Annual Cash & Cash Equivalents
$11.59B$1.87B-13.87%
Summary
- Current Value
- As of today, NVS annual cash & cash equivalents is $11.59B, down -13.87% on
- Historical Performance
- NVS annual cash & cash equivalents is down -38.77% over the past 3 years, up +0.23% over the past 5 years
- All-Time High Comparison
- NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on
- 3-Year Low Comparison
- NVS annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- NVS annual cash & cash equivalents is higher than 99.47% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $11.59B | -13.9% | -38.8% | +0.2% | +42.2% | |
| Quarterly Cash & Cash Equivalents | $7.69B | +9.9% | -31.2% | +43.6% | +37.2% | |
| Price | $156.24 | +22.8% | +54.7% | +67.4% | +218.5% | |
| Annual Current Assets | $30.46B | +2.5% | -17.5% | +2.6% | +13.9% | |
| Annual Total Liabilities | $69.02B | +10.2% | +10.7% | -8.6% | +28.6% | |
| Annual Working Capital | $3.18B | +214.4% | -61.5% | +194.0% | +56.6% | |
| Annual Net Income | $14.04B | +17.6% | +131.6% | +72.9% | +42.0% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $18.93B | N/A | -38.8% |
| 5Y | $28.33B | -59.1% | |
| All | $28.33B | -59.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $11.59B | at low | |
| 5Y | $11.56B | N/A | +0.2% |
| All | $5.08B | +128.4% |
Cash and Cash Equivalents History
FAQ
- What is the current annual cash & cash equivalents of NVS?
- As of today, NVS annual cash & cash equivalents is $11.59B
- What is 1-year change in NVS annual cash & cash equivalents?
- NVS annual cash & cash equivalents is down -13.87% year-over-year
- What is 3-year change in NVS annual cash & cash equivalents?
- NVS annual cash & cash equivalents is down -38.77% over the past 3 years
- How far is NVS annual cash & cash equivalents from its all-time high?
- NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on December 31, 2021
- How does NVS annual cash & cash equivalents rank versus sector peers?
- NVS annual cash & cash equivalents is higher than 99.47% of companies in Healthcare sector
- When is NVS next annual earnings release?
- As of today, the next annual earnings release for NVS has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$7.69B$713.02M+10.22%
Summary
- Current Value
- As of today, NVS quarterly cash & cash equivalents is $7.69B, up +10.22% on
- Historical Performance
- NVS quarterly cash & cash equivalents is up +9.86% year-over-year, down -31.18% over the past 3 years
- All-Time High Comparison
- NVS quarterly cash & cash equivalents is currently -72.85% below its historical high of $28.33B set on
- 3-Year Low Comparison
- NVS quarterly cash & cash equivalents is +10.22% above its 3-year low of $6.98B reached on
- Sector Comparison
- NVS quarterly cash & cash equivalents is higher than 98.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $7.69B | +10.2% | +9.9% | -31.2% | +43.6% | |
| Annual Cash & Cash Equivalents | $11.59B | – | -13.9% | -38.8% | +0.2% | |
| Price | $156.24 | +3.9% | +22.8% | +54.7% | +67.4% | |
| Quarterly Current Assets | $27.35B | +2.8% | +5.4% | -18.3% | +14.9% | |
| Quarterly Total Liabilities | $80.09B | +0.6% | +28.5% | +35.6% | +14.6% | |
| Quarterly Working Capital | -$4.40B | +7.8% | +23.9% | -377.6% | +24.5% | |
| Quarterly Net Income | $3.26B | +2.9% | -20.3% | +43.6% | +12.6% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.59B | -33.6% | |
| 3Y | $14.43B | -46.7% | |
| 5Y | $28.33B | -72.8% | |
| All | $28.33B | -72.8% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.98B | +10.2% | |
| 3Y | $6.98B | +10.2% | |
| 5Y | $5.36B | N/A | +43.6% |
| All | $2.64B | +191.5% |
Quarterly Cash & Cash Equivalents History
FAQ
- What is the current quarterly cash & cash equivalents of NVS?
- As of today, NVS quarterly cash & cash equivalents is $7.69B
- What is NVS quarterly cash & cash equivalents most recent change?
- NVS quarterly cash & cash equivalents was up +10.22% on June 30, 2026
- What is 1-year change in NVS quarterly cash & cash equivalents?
- NVS quarterly cash & cash equivalents is up +9.86% year-over-year
- How far is NVS quarterly cash & cash equivalents from its all-time high?
- NVS quarterly cash & cash equivalents is currently -72.85% below its historical high of $28.33B set on December 31, 2021
- How does NVS quarterly cash & cash equivalents rank versus sector peers?
- NVS quarterly cash & cash equivalents is higher than 98.84% of companies in Healthcare sector
- When is NVS next earnings release?
- The next earnings release for NVS is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- NVS Official Website www.novartis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
- NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
- NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs